Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

175.02 +1.00 (+0.57%)
Streaming Delayed Price Updated: 11:10 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
News headline image
Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday? ↗
The U.S. stock market saw modest gains in a session characterized by low trading volumes following the Christmas holiday. The S&P 500 Index gained 0.3% during midday trading in New York, eyeing its... 
Via Benzinga
News headline image
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday? ↗
The S&P 500 and Nasdaq 100 indices are on the verge of achieving an impressive eight consecutive weeks of gains following a more significant decline than expected in the Federal Reserve’s favored... 
Via Benzinga
Topics Economy Stocks
News headline image
US Stocks Bounce; Chipmakers, Cruise Lines Lead, Dollar Falls: What's Driving Markets Thursday? ↗
On Thursday, Wall Street rebounded into positive territory, following a brief dip experienced on Wednesday. At midday trading New York time, all major stock indices were trading in the green as traders... 
Via Benzinga
News headline image
Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday? ↗
Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs. 
Via Benzinga
News headline image
Biotech Is Coming Back, Can The Run Last? ↗
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally. 
Via Talk Markets
News headline image
MarketBeat Week in Review – 12/4 - 12/8
Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week 
Via MarketBeat
Topics Economy
News headline image
Three Lessons For Investing In Biotech Companies ↗
Many successful blockbusters started with a small trial. But you should temper your expectations until a larger, more rigorous trial is conducted. 
Via Talk Markets
News headline image
3 biotech powerhouses poised to thrive amid sector rebound
If the newfound support and uptrend in the biotech sector last, as the new year quickly approaches, the biotech sector could shift from lagger to leader. 
Via MarketBeat
Topics ETFs
News headline image
Biotech reversal confirmed: what's ahead for the IBB?
The recent reversal and reclaim of the significant $124 support level in the IBB holds importance, indicating a potential shift in momentum. 
Via MarketBeat
Topics ETFs
News headline image
Biotech And Healthcare Portfolio Playbook For December 2023/24 ↗
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. 
Via Talk Markets
News headline image
Are You A Trader Or Investor: Biotech Momentum Is Picking Up ↗
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. 
Via Talk Markets
Topics ETFs
News headline image
You Don't Have to Pick a Winner in Biotech. Here's Why. ↗
If you invest over the long term, you'll increase your chances of victory. 
Via The Motley Fool
News headline image
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures ↗
Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments. 
Via InvestorPlace
News headline image
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech ↗
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic. 
Via Talk Markets
News headline image
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... ↗
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
Via Talk Markets
Topics Economy
News headline image
When News Moves So Fast, Stocks Can Stand Still ↗
As far as the market goes, it feels like time is standing still. 
Via Talk Markets
News headline image
Johnson & Johnson Stock: Is Now the Time to Sell? ↗
Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff 
Via InvestorPlace
News headline image
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up ↗
Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment. 
Via Talk Markets
News headline image
Fresh Look At Long Bonds ↗
As long as the S&P 500 outperforms long bonds (TLT) risk is on. 
Via Talk Markets
Topics Bonds Stocks
News headline image
Healthcare Playbook Revisited - Growth Plus Value ↗
Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on. 
Via Talk Markets
News headline image
Time For Gilead Sciences-Heavy ETFs? ↗
Gilead Sciences has underperformed the broader market this year by a hefty margin. 
Via Talk Markets
News headline image
Technical Correction Or Return Of The Bear Market? ↗
The QQQ chart right now has a few key aspects. 
Via Talk Markets
News headline image
It’s Really All About the Retail Sector Now ↗
Should XRT break the July calendar range low, we will once again be talking about the 80-month moving average or the 6–7-year business cycle low. 
Via Talk Markets
News headline image
The 3 Best Biotech Stocks to Buy Now: September 2023 ↗
With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize. 
Via InvestorPlace
News headline image
Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed ↗
 
Via Benzinga
Topics ETFs
News headline image
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio? ↗
It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. 
Via Talk Markets
Topics ETFs
News headline image
BRICS And The Recent Headline ↗
At a time when the world is experiencing de-globalization, an alliance of countries including Brazil, Russia, China, South Africa and possibly India is a potential threat to the west. 
Via Talk Markets
News headline image
The US Dollar And Long Bonds Doing The Dosey Doe ↗
With BRICS happening ahead of Jackson Hole, it would be good to look at the technical charts on both the dollar and the long bonds. 
Via Talk Markets
News headline image
5 Meme Stocks to Sell Immediately, According to AI ↗
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Biotechnology On Drugs ↗
​​​​​​​Biotechnology has traded basically sideways since the start of 2023. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.